Indian drug manufacturing company gets permission for a good cause
US Food and Drug Administration permits Zydus Cadila to manufacture medicine to treat schizophreniac patients
Published:
12 Sep 2021 08:00am IST
12 Sep 2021 08:00am IST
Schizophrenia is a mental illness or a psychosis. To explain in medical terms, psychosis is a stage when a person gradually gets detached from the practical world and mentally gets involved in an imaginary world. There is no fixed age as when one can suffer from this disease but it is common in between 25 to 50 years. At times aged people might also suffer from this mental illness.
Researchers are going all over the world to find the exact cause of schizophrenia but some researchers have also concluded that it might be a result of the imbalance of a hormone called dopamine. The person affected with schizophrenia might show symptoms like paranoia, fearfulness, unnatural and irrelevant talks, might also suffer from some delusions.
In context to schizophrenia, a city-based psychiatrist, Dr Manika Das (name changed) said, "It is very common nowadays but there is a relief that we have many medicines and ways to treat schizophrenia".
This Ahmadabad-based pharmaceutical group has so far received 321 approvals and it was added that the medicine Brexpiprazole will be manufactured in their manufacturing firm at the SEZ, Ahmedabad.Another sign of relief is that medicine company of Indian Origin Zydus Cadila on Thursday made it public that they have received tentative approval from the US Food and Drug Administration (USFDA) to market Brexpiprazole tablets in the strengths of 0.25mg, 0.5mg, 1mg, 2mg and 4mg.
Brexpiprazole is an atypical antipsychotic indication to be an adjunctive therapy. This medicine is used for treating major depressive disorders and for the treatment of schizophrenia.
This Ahmadabad-based pharmaceutical group has so far received 321 approvals and it was added that the medicine Brexpiprazole will be manufactured in their manufacturing firm at the SEZ, Ahmedabad.
Be the first to start a discussion here. Sign-in to write a comment now!
